Prostate cancer has varying prognoses.The extremes of the disease spectrum involve well-differentiated prostate cancer that can be considered almost normal ageing without any significant effect on the patient's prognosis, and poorly differentiated, invasive carcinoma that requires active treatment.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
The selection of an appropriate line of treatment for each patient requires reliable assessment of the extent, aggressiveness and risk of recurrence of the disease. Multiparametric magnetic resonance imaging has improved the detection of prostate cancer and the assessment of its aggressiveness and local extent. Magnetic resonance imaging enables the detection of the most suspicious target for taking a biopsy specimen.
Duodecim; lääketieteellinen aikakauskirja. 2015 [Epub]
Anu Kenttämies, Antti Rannikko